Compensation for respiratory motion by gated radiotherapy: an experimental study.

Respiratory organ motion is known to be one of the largest intrafractional organ motions. Therefore, it is important to investigate the potential benefit of gated dose delivery approaches which aim to account for the respective dose uncertainties. In this study respiration is simulated by a moving lung phantom; the movement is not restricted to a normal sinusoidal progression and simulates the one of the embedded lung tumour in the cranial-caudal direction. An IMRT plan with a total of 29 beam segments was designed for the treatment of this tumour. It was irradiated in its resting position-which is the position at exhalation-and during movement. Furthermore the irradiation was triggered using different amplitude thresholds, which means that the irradiation only proceeded if the deviation of the tumour's position from its resting position is smaller than the given threshold. We determined the gating-related increase of the treatment time for various gating procedures. We also measured the resulting dose distribution in specific slices of the phantom perpendicular to the direction of the movement using film dosimetry and compared it to the dose distribution of the static case. Since these film measurements cannot be done inside the whole tumour, additionally the movement and gating was simulated using the planning software to calculate the 3D dose distribution inside the tumour and to generate dose volume histograms for different treatment modalities. The total treatment time was observed to increase by 20%-100% depending on the individual gating threshold and can be calculated easily. The analysis of the films showed that irradiation without gating leads to significant underdosages up to 33%, especially at the edge of the tumour. With gating it is possible to considerably reduce this underdosage down to 9% depending on the trigger threshold. The calculation of the dose volume histograms makes it possible to find a reasonable compromise between the improvement of the dose distribution and the increase of the treatment time.